3.4 Other Toxicities
Treatment related adverse events (TRAEs) that occurred in
>10% of patients are shown in Table 2 . All
patients experienced some degree of anemia, lymphopenia, neutropenia,
thrombocytopenia, leukopenia and nausea. Other common TRAEs included
sinus tachycardia (83%), fatigue (83%), increased alanine
aminotransferase (75%), anorexia (75%), vomiting (67%), increased
alkaline phosphatase (67%) and hypertension (67%).